Clinical case of endovascular repair of abdominal aortic aneurysm in patient with multifocal atherosclerosis

Background. Until now, the issue of surgical treatment staging in patients with aortic pathology coexisting with coronary artery disease and atherosclerosis of the peripheral arteries remains controversial because of features of each clinical situation and association with the risk of periprocedural life-threatening complications (ruptured aortic aneurysm, myocardial infarction, stroke).
Objective. Present a clinical case of successful treatment of a patient with an abdominal aortic aneurysm, clinically significant lesions of the coronary and carotid arteries.
Design and methods. Diagnosis was carried out using computed tomography of the aorta with intravenous contrast. Instrumental examination included electrocardiography, echocardiography (EchoCG), ultrasound dopplerography of the BCA. Coronary angiography with BCA angiography was also performed.
Results. Clinical diagnosis is an ischemic heart disease, angina pectoris III FC, chronic heart failure II FC and atherosclerosis of the aorta. Aneurysm of the abdominal aorta (diameter 96 mm), stenosing atherosclerosis of the BCA, PVCA stenosis 80 % and occlusion of the LVCA were observed. Patient had hypertension stage III and risk of CVE 4. Firstly, the patient was underwent stenting of the right internal carotid artery, than coronary artery bypass grafting and on the last stage he was performed — endovascular aotric repair. There were no complications in the perioperative period.
Conclusions. Endovascular repair of abdominal aotric aneurysm is an effective method of treating patients with comorbid conditions. However, it is possible the development of fatal cardiovascular complications in patients with combined atherosclerotic lesions of brachiocephalic and coronary arteries that is why they are required a multidisciplinary approach for choosing a safe treatment strategy.

1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age sex specific all-cause and cause specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385:117–171. DOI: 10.1016/S0140-6736(14)61682-2.

2. Oganov RG, Kontsevaya AV, Kalinina AM. Economic burden of cardiovascular disease in the Russian Federation. Cardiovascular therapy and prevention. 2011; 10(4):4–9. In Russian [Оганов Р.Г., Концевая А.В., Калинина А.М. Экономический ущерб от сердечно-сосудистых заболеваний в Российской Федерации. Кардиоваскулярная терапия и профилактика. 2011; 10(4):4–9]. DOI: 10.20996/1819-6446-2018-14-2-156-166.

3. Nichols M, Townsend N, Luengo-Fernandez R, et al., European Cardiovascular Disease Statistics, European Heart Network. (European Society of Cardiology, Sophia Antipolis). https://www.escardio.org/static_file/Escardio/Pressmedia/pressreleases/2013/EU-cardiovasculardisease-statistics-2012.pdf (2012)

4. Ashton HA, Buxton MJ, Day NE, et al. Multicentre Aneurysm Screening Study G. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002; 360:1531–1539. DOI: 10.1016/s0140-6736(02)11522-4.

5. Benson RA, Poole R, Murray S, et al. Screening results from a large United Kingdom abdominal aortic aneurysm screening center in the context of optimizing United Kingdom National abdominal aortic aneurysm Screening Programme protocols. Journal of vascular surgery. 2016; 63:301–304. DOI: 10.1016/j.jvs.2015.08.091.

6. Powell JT, Brady AR, Brown LC, et al. The UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet. 1998; 352:1649–1655. DOI: 10.1016/S0140-6736(98)10137-X.

7. Aboyans V, Ricco JB, Bartelink MLE, et al. ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018; 39(9):763–816. DOI: 10.1093/eurheartj/ehx095.

8. Alekyan BG, Pokrovsky AV, Karapetyan NG, et al. A multidisciplinary approach in determining of prevalence of coronary artery disease and treatment strategies in patients with pathology of the aorta and peripheral arteries. Russ J Cardiol. 2019; 24(8):8–16. In Russian

9. Savji N, Rockman CB, Skolnick AH, et al. Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects. J Am Coll Cardiol. 2013; 61:1736–1743. DOI: 10.1016/j.jacc.2013.01.054.

10. Steg PG, Bhatt DL, Wilson PW, et al. Oneyear cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007; 297(11): 1197–1206. DOI: 10.1001/jama.297.11.1197.

11. Smilowitz NR, Gupta N, Ramakrishna H, et al. Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery. JAMA Cardiol. 2017; 2(2):181–187. DOI: 10.1001/jamacardio.2016.4792.

12. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014; 35(35):2383–2431. DOI: 10.1093/eurheartj/ehu282.

13. IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002; 359:1269–1275. DOI: 10.1016/S0140-6736(02)08265-X.

14. Mangano DT. Adverse outcomes after surgery in the year 2001--a continuing odyssey. Anesthesiology. 1998; 88(3):561–564. DOI: 10.1097/00000542-199803000-00001.

15. Roger VL, Ballard DJ, Hallett JW Jr, et al. Influence of coronary artery disease on morbidity and mortality after abdominal aortic aneurysmectomy: a population-based study, 1971–1987. J Am Coll Cardiol. 1989; 14:1245–1252. DOI: 10.1016/0735-1097(89)90423-3.

16. Blankensteijn JD, de Jong SE, Prinssen M, et al. Dutch Randomized Endovascular Aneurysm Management (DREAM) Trial Group. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2005; 352(23):2398–2405. DOI: 10.1056/NEJMoa051255.

17. Chernyavsky AM, Karaskov AM, Mironenko SP, et al. Surgical correction of multifocal atherosclerosis. The Siberian Scientific Medical Journal. 2006; 2: 126–131. In Russian

18. Matsumura JS, Brewster DC, Makaroun MS, et al. A multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysm. J Vasc Surg. 2003; 37:262–271. DOI: 10.1067/mva.2003.120.